Hepatitis Hepatitis  Cost effectiveness studies have found widespread vaccination of adults to not be feasible, but have stated that a combination hepatitis A and B vaccination of children and at risk groups  may be. Hepatitis B accounts for a much larger percentage of health care spending in endemic regions like Asia.  In 1997 it accounted for 3. 2% of South Korea's total health care expenditures and resulted in $696 million in direct costs.  A large majority of that sum was spent on treating disease symptoms and complications.  Chronic hepatitis B infections are not as endemic in the United States, but accounted for $357 million in hospitalization costs in the year 1990.  That number grew to $1 Hepatitis Hepatitis